butorphanol has been researched along with Opioid-Related Disorders in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 13 (52.00) | 18.2507 |
2000's | 7 (28.00) | 29.6817 |
2010's | 1 (4.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balhara, YPS; Gupta, R; Sarkar, S; Shah, B | 1 |
Jang, CG; Lee, KW; Lee, SY; Tian, YH; You, IJ | 1 |
Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Tanaka, S; Tien, LT | 1 |
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT | 1 |
Chudapongse, N; Fan, LW; Ho, IK; Ma, T; Rockhold, RW; Sinchaisuk, S; Tanaka, S; Tien, LT | 1 |
Chudapongse, N; Ho, IK; Kim, SY; Lee, SM; Levin, MC; Oh, JT; Park, HJ | 1 |
Fan, LW; Ho, IK; Liu-Chen, LY; Park, Y; Rockhold, RW; Tanaka, S; Tien, LT | 1 |
Feng, Y; Ho, IK; Tokuyama, S; Wakabayashi, H | 2 |
Jasinski, DR; Preston, KL; Sullivan, JT; Testa, M | 1 |
Ho, IK; Hoskins, B; Jaw, SP | 1 |
Ho, IK; Hoskins, B; Tokuyama, S; Wakabayashi, H | 1 |
Ho, IK; Tokuyama, S | 1 |
Feng, YZ; Ho, IK; Hoshi, K; Rockhold, RW; Tokuyama, S | 1 |
Ho, IK; Rockhold, RW; Zhu, H | 1 |
Barta, PE; Bigelow, GE; Greenberg, BD; Lancaster, E; Pearlson, GD; Preston, KL; Schlaepfer, TE; Strain, EC | 1 |
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W | 1 |
Ho, IK; Jang, CG; Rockhold, RW | 1 |
Glatt, W | 1 |
Ho, IK; Tokuyama, S; Yamamoto, T | 1 |
Greenwald, MK; Stitzer, ML | 1 |
Bigelow, GE; Liebson, IA; Preston, KL | 2 |
Bickel, W; Bigelow, G; Liebson, I; Preston, K | 1 |
Balster, RL; Lukas, SE | 1 |
3 review(s) available for butorphanol and Opioid-Related Disorders
Article | Year |
---|---|
Glutamate in opioid dependence.
Topics: Analgesics, Opioid; Animals; Butorphanol; Glutamic Acid; Locus Coeruleus; Microdialysis; Opioid-Related Disorders; Rats; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1997 |
The role of glutamate in physical dependence on opioids.
Topics: Analgesics, Opioid; Animals; Butorphanol; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Neurons, Afferent; Opioid-Related Disorders; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1998 |
Review of self-administration.
Topics: Animals; Buprenorphine; Butorphanol; Cyclazocine; Humans; Macaca mulatta; Morphinans; Morphine; Nalbuphine; Opioid-Related Disorders; Papio; Pentazocine; Rats; Reinforcement, Psychology; Self Administration | 1985 |
5 trial(s) available for butorphanol and Opioid-Related Disorders
Article | Year |
---|---|
Psychopharmacology and abuse potential of transnasal butorphanol.
Topics: Administration, Intranasal; Adult; Arousal; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intramuscular; Male; Middle Aged; Opioid-Related Disorders; Pain Measurement | 1994 |
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
Topics: Amygdala; Brain; Butorphanol; Cerebrovascular Circulation; Double-Blind Method; Emotions; Euphoria; Gyrus Cinguli; Humans; Hydromorphone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Placebos; Receptors, Opioid; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon | 1998 |
A new method for detoxifying opioid-dependent patients.
Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Butorphanol; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 1999 |
Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
Topics: Adult; Arousal; Brain; Butorphanol; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Heroin Dependence; Humans; Hypnotics and Sedatives; Lorazepam; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1998 |
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Topics: Adult; Butorphanol; Cognition; Double-Blind Method; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome | 1988 |
17 other study(ies) available for butorphanol and Opioid-Related Disorders
Article | Year |
---|---|
Injection Butorphanol dependence: A case report.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Butorphanol; GABA Modulators; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nitrazepam; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat.
Topics: Analgesics, Opioid; Animals; Brain; Butorphanol; Cell Count; Disease Models, Animal; Enzyme Inhibitors; Indazoles; Male; Narcotic Antagonists; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2008 |
Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Topics: Analgesics, Opioid; Animals; Binding Sites; Binding, Competitive; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Neurons; Opioid-Related Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Up-Regulation | 2002 |
Butorphanol dependence and withdrawal decrease hippocampal kappa 2-opioid receptor binding.
Topics: Animals; Butorphanol; Hippocampus; Male; Opioid-Related Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 2002 |
Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Topics: Animals; Behavior, Animal; Brain; Butorphanol; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Up-Regulation | 2003 |
Proteomic analysis of phosphotyrosyl proteins in the rat brain: effect of butorphanol dependence.
Topics: Animals; Brain; Butorphanol; Male; Opioid-Related Disorders; Phosphorylation; Phosphotyrosine; Proteins; Proteomics; Rats; Rats, Sprague-Dawley | 2004 |
Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression.
Topics: Animals; Brain; Butorphanol; Disease Models, Animal; Down-Regulation; Gene Expression; Hippocampus; Injections, Intraventricular; Male; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome; Up-Regulation | 2005 |
Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Opioid-Related Disorders; Pons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Opioid antagonists and butorphanol dependence.
Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1993 |
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Behavior, Animal; Butorphanol; Cytosol; Enzyme Inhibitors; Isoquinolines; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Piperazines; Pons; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1995 |
Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
Topics: Animals; Biogenic Amines; Biogenic Monoamines; Brain Chemistry; Butorphanol; Injections, Intraperitoneal; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
Topics: Animals; Butorphanol; Calcium Channel Blockers; Diltiazem; Glutamic Acid; Locus Coeruleus; Male; Microdialysis; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1996 |
Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine; Morphine Dependence; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord; Substance Withdrawal Syndrome | 1998 |
Withdrawal from butorphanol dependence alters binding of [3H]phorbol dibutyrate to protein kinase C, but not of [3H]forskolin to adenylate cyclase.
Topics: Adenylyl Cyclases; Animals; Autoradiography; Brain; Brain Chemistry; Butorphanol; Carcinogens; Colforsin; Male; Narcotic Antagonists; Opioid-Related Disorders; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tritium | 1999 |
A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Butorphanol; Cerebral Cortex; Corpus Striatum; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Mesencephalon; Morphine; Naloxone; Opioid-Related Disorders; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley | 2000 |
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Topics: Butorphanol; Heart Rate; Humans; Hydromorphone; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1987 |
Drug discrimination in human post-addicts: agonist/antagonist opioids.
Topics: Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pentazocine | 1988 |